

<!-- page 1 -->

w;s úfYI
wxl 2123$35 - 2019 uehs ui 15 jeks nodod - 2019'05'15
No. 2123/35  -  WEDNESDAY   MAY  15,  2019
EXTRAORDINARY
Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha .eiÜ m;%h
The Gazette of the Democratic Socialist Republic of Sri Lanka
(Published by Authority)
PART I : SECTION (I) — GENERAL
Government Notifications
                  
       
              
               
            
        
                  
     
         
             
         
               
            
               
               
            
               
        
                 
        
              
               
            
         
                  
This Gazette Extraordinary can be downloaded from www.documents.gov.lk
1A - PG  4518— 617 (05/2019)
LD.-B 9/2016
THE   NATIONAL   MEDICINES   REGULATORY   AUTHORITY   ACT,   No  .5   OF   2015
REGULATIONS made by the Minister of Health, Nutrition and Indigenous Medicine under section 142 read together
with section 118 of the National Medicines Regulatory Authority Act, No. 5 of 2015.
DR. R AJITHA S ENARATNE,
Minister of Health, Nutrition and
 Indigenous Medicine.
Colombo,
11th May, 2019.
Regulations
1. These regulations may be cited as the Medicines (Ceiling on Prices) Regulations, 2019 and shall come into
operation on the date of publication of these regulations in the Gazette (hereinafter referred to as the “relevant date”).
2. There shall be a ceiling on prices of the medicines set out in the Schedule hereto (hereinafter referred to as
“scheduled medicines”) from and after the relevant date.
3. The Maximum Retail Price limits in respect of the scheduled medicines shall be applicable to all brand names
and generic names of the scheduled medicines.

<!-- page 2 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 20 19'05'15
PART I : SEC. (I) - GAZETTE   EXTRAORDINARY   OF   THE   DEMOCRATIC   SOCIALIST   REPUBLIC   OF   SRI   LANKA - 15.05.2019
2A
4. On and after the relevant date, no manufacturer, importer, trader, distributor,pharmacist, medical practitioner,
dentist, veterinary surgeon,medical institution including a private medical institution, pharmacy or person who or which is
in possession of any scheduled medicine set out in column II of the Schedule hereto,for the purpose of sale shall sell such
medicine above the Maximum Retail Price stipulated in the corresponding entry in column V  thereof.
5.Every person or institution referred to in regulation 4, who sells or offer for sale any medicine set out in the
Schedule hereto, shall upon such sale issue a receipt clearly indicating the appropriate name and the price of such medicine.
6. Any manufacturer or importer who is in possession of a scheduled medicine for the purpose of sale who
currently sells such medicine at a price less than the Maximum Retail Price stipulated in the Schedule may increase the
existing price by only Fourteen Decimal Four per centum (14.4%) and any trader, distributor, pharmacist, medical
practitioner, dentist, veterinary surgeon, medical institution including a private medical institution, pharmacy or person
who or which is in possession of such scheduled medicine for the purpose of sale shall maintain such medicine at such
revised price.
 7. Where any dosage form or strength  of the scheduled medicine is not specified in such schedule, the maximum
retail price limit for the dosage form or strength  not so specified shall be the maximum retail price limit as shall be fixed
by the National Medicines Regulatory Authority.
8. The Maximum Retail Price as set out in the Schedule hereto or the  current retail price, whichever is less, of
each unit of item in the stock of the scheduled medicines manufactured or available in the market, medical institution
including a private medical institution, pharmacy or person who or which is in possession of such medicine for the
purpose of sale on the relevant date shall be printed or marked on its commercial package or label as expeditiously as
practicable, so however, before the expiry of a period of Forty- five days from the relevant date.
 9. Notwithstanding the provisions of regulation 8, the Maximum Retail Price of each unit shall be as set out in
the Schedule on and after the relevant date. The Maximum Retail Price  set out in the Schedule shall continue to be valid
and effectual from the relevant date.
10. Any manufacturer, importer, trader, distributor, pharmacist, medical practitioner, dentist, veterinary
surgeon,medical institution including a private medical institution, pharmacy or person who or which is in possession of
a scheduled medicine for the purpose of sale, who contravenes the provisions of these regulations commits an offence
and shall be triable under section 131 of the National Medicines Regulatory Authority Act, No.5 of 2015.
11. It shall be the duty of every manufacturer, importer, trader, distributor, pharmacist, medical practitioner,
dentist, veterinary surgeon,medical institution including a private medical institution, pharmacy or person who or which is
in possession of scheduled medicines for the purpose of sale, to display at every retail outlet the Maximum Retail Price
of the scheduled medicines set out in the Schedule hereto.
12. The (Ceiling on Prices) Regulations, No. 2 of 2016 published in the Gazette Extraordinary No. 1989/61 of
October 21, 2016 as amended by regulations published in Gazette Extraordinary No. 2049/31 of December 14, 2017 and
by regulations published in Gazette Extraordinary No. 2086/37 of August 31, 2018 are hereby rescinded.
13. For the purpose of these regulations –
“dentist” shall have the same meaning as in the Medical Ordinance (Chapter 105);
“medical practitioner” shall have the same meaning as in the Medical Ordinance (Chapter 105);
“private medical institution” shall have the same meaning assigned to it by the Private Medical Institutions
(Registration) Act, No. 21 of 2006;
“veterinary surgeon” means a person registered as a Veterinary Surgeon or a Veterinary Practitioner
under the Veterinary Surgeons and Practitioners Act, No. 46 of 1956.

<!-- page 3 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 20 19'05'15
PART I : SEC. (I) - GAZETTE   EXTRAORDINARY   OF   THE   DEMOCRATIC   SOCIALIST   REPUBLIC   OF   SRI   LANKA - 15.05.2019
3A
SCHEDULE
MAXIMUM   RETAIL   PRICES   OF   MEDICINES
Column Column II Column III Column IV Column V
I Generic Name Route of S trength Ceiling
Administration/ Maximum
Dosage forms Retail Price
(SLR)
1 ALBENDAZOLE T ablet/ capsule 400mg 36.04
2 AMOXICILLIN+CLA VULANIC  ACID Oral suspension 156mg/ 5ml 345.35
AMOXICILLIN+CLA VULANIC  ACID Tablet/ capsule 375mg 42.52
AMOXICILLIN+CLA VULANIC  ACID Tablet/ capsule 625mg 72.07
AMOXICILLIN+CLA VULANIC  ACID Injection 1.2g 757.96
3 CLARITHROMYCIN Tablet/ capsule 250mg 43.85
CLARITHROMYCIN Tablet/ capsule 500mg 88.89
CLARITHROMYCIN Oral suspension 125mg/5ml 523.72
4 AZITHROMYCIN Tablet/ capsule 250 mg 45.17
AZITHROMYCIN Tablet/ capsule 500 mg 63.37
AZITHROMYCIN Oral suspension 200mg/ 5ml 210.21
5 CEFUROXIME Tablet/ capsule 250 mg 54.66
CEFUROXIME Tablet/ capsule 500 mg 87.21
6 DOXYCYCLIN Tablet/ capsule 100 mg 12.14
7 ACICLOVIR T ablet/ capsule 200 mg 44.44
8 CIPROFLOXACIN Tablet/ capsule 250 mg 6.91
CIPROFLOXACIN Tablet/ capsule 500 mg 10.22
9 LEVOFLOXACIN T ablet/ capsule 250 mg 29.07
LEVOFLOXACIN T ablet/ capsule 500 mg 48.05
10 CEPHALEXIN Tablet/ capsule 250 mg 9.85
CEPHALEXIN Tablet/ capsule 500 mg 18.02
CEPHALEXIN Oral suspension 125 mg/5 ml 318.32

<!-- page 4 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 20 19'05'15
PART I : SEC. (I) - GAZETTE   EXTRAORDINARY   OF   THE   DEMOCRATIC   SOCIALIST   REPUBLIC   OF   SRI   LANKA - 15.05.2019
4A
11 CEFIXIME T ablet/ capsule 100 mg 27.63
CEFIXIME T ablet/ capsule 200 mg 51.30
CEFIXIME Oral suspension 100 mg/5 ml 414.41
12 AMLODIPINE T ablet/ capsule 5 mg 18.38
AMLODIPINE T ablet/ capsule 10 mg 25.59
13 DILTIAZEM T ablet/ capsule 30 mg 3.25
DILTIAZEM T ablet/ capsule 60 mg 10.70
DILTIAZEM T ablet/ capsule 90 mg 25.71
14 LOSARTA N POTASS IUM T ablet/ capsule 25 mg 8.83
LOSARTA N POTASS IUM T ablet/ capsule 50 mg 12.38
15 LOSARTA N + Hydrochlorothiazide Tablet/ capsule 62.5 mg 23.36
16 ENALAPRIL T ablet/ capsule 5 mg 7.21
ENALAPRIL T ablet/ capsule 10 mg 12.14
17 ATE NOLOL T ablet/ capsule 25mg 3.60
ATE NOLOL T ablet/ capsule 50 mg 5.29
ATE NOLOL T ablet/ capsule 100 mg 15.62
18 NIFEDIPINE – sustained release Tablet/ capsule 20 mg 4.45
19 CLOPIDOGREL T ablet/ capsule 75 mg 21.03
2 0 A TOR V AST A TIN Tablet/ capsule 5mg 7.72
A T ORV ASTA T IN Tablet/ capsule 10 mg 13.40
A T ORV ASTA T IN Tablet/ capsule 20 mg 21.14
A TOR V AST A TIN Tablet/ capsule 40 mg 29.74
SCHEDULE (Contd.)
MAXIMUM   RETAIL   PRICES   OF   MEDICINES
Column Column II Column III Column IV Column V
I Generic Name Route of S trength Ceiling
Administration/ Maximum
Dosage forms Retail Price
(SLR)

<!-- page 5 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 20 19'05'15
PART I : SEC. (I) - GAZETTE   EXTRAORDINARY   OF   THE   DEMOCRATIC   SOCIALIST   REPUBLIC   OF   SRI   LANKA - 15.05.2019
5A
21 ROSUV ASTAT IN T ablet/ capsule 5 mg 25.83
ROSUV ASTAT IN T ablet/ capsule 10 mg 44.44
22 TELMISARTA N T ablet/ capsule 20 mg 12.25
TELMISARTA N T ablet/ capsule 40 mg 19.46
TELMISARTA N T ablet/ capsule 80mg 36.52
23 ASPIRIN T ablet/ capsule 75 mg 3.60
ASPIRIN T ablet/ capsule 100 mg 6.37
24 METFORMIN T ablet/ capsule 500 mg 4.75
METFORMIN-sustained release Tablet/ capsule 500 mg 9.25
METFORMIN T ablet/ capsule 850 mg 8.89
25 GLIBENCLAMIDE T ablet/ capsule 5 mg 2.64
26 GLICLAZIDE T ablet/ capsule 80mg 13.58
27 THYROXINE T ablet/ capsule 50 mcg 7.33
THYROXINE T ablet/ capsule 100 mcg 10.94
28 GLIPIZIDE T ablet/ capsule 5 mg 9.50
29 IBUPROFEN Tablet/ capsule 200 mg 1.33
IBUPROFEN T ablet/ capsule 400mg 4.45
30 DICLOFENAC SODIUM T ablet/ capsule 50 mg 15.62
DICLOFENAC SODIUM T ablet/ capsule 100 mg 18.14
31 DICLOFENAC POTASSIUM T ablet/ capsule 50 mg 13.16
32 PARACETAMOL T ablet/ capsule 500 mg 1.57
33 SODIUM V ALPROA TE T ablet/ capsule 200 mg 10.81
SCHEDULE (Contd.)
MAXIMUM   RETAIL   PRICES   OF   MEDICINES
Column Column II Column III Column IV Column V
I Generic Name Route of S trength Ceiling
Administration/ Maximum
Dosage forms Retail Price
(SLR)

<!-- page 6 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 20 19'05'15
PART I : SEC. (I) - GAZETTE   EXTRAORDINARY   OF   THE   DEMOCRATIC   SOCIALIST   REPUBLIC   OF   SRI   LANKA - 15.05.2019
6A
SCHEDULE (Contd.)
MAXIMUM   RETAIL   PRICES   OF   MEDICINES
Column Column II Column III Column IV Column V
I Generic Name Route of S trength Ceiling
Administration/ Maximum
Dosage forms Retail Price
(SLR)
34 RISPERIDONE Tablet/ capsule 1 mg 9.50
RISPERIDONE Tablet/ capsule 2 mg 11.11
35 OLANZAPINE T ablet/ capsule 5 mg 12.01
OLANZAPINE T ablet/ capsule 10 mg 24.98
36 CARBAMAZEPINE T ablet/ capsule 200 mg 14.41
37 ALPRAZOLAM T ablet/ capsule 0.25 mg 7.81
ALPRAZOLAM T ablet/ capsule 0.5 mg 1 1.90
38 FLUOXETINE T ablet/ capsule 20 mg 13.21
39 GABAPENTIN T ablet/ capsule 100 mg 20.12
GABAPENTIN T ablet/ capsule 300 mg 39.82
40 BECLOMETHASONE DP capsule (inhalation) 200 mcg 7.21
BECLOMETHASONE DP capsule (inhalation) 400 mcg 8.17
BECLOMETHASONE Metered dose inhaler (200 doses)100 mcg 609.61
BECLOMETHASONE Metered dose inhaler (200 doses)250 mcg 673.87
41 SALBUTAMOL DP capsule (inhalation) 200 mcg 4.80
SALBUTAMOL DP capsule (inhalation) 400 mcg 6.61
SALBUTAMOL Metered dose inhaler (200doses)100 mcg 372.37
42 METHYL PREDNISOLONE T ablet/ capsule 4 mg 14.23
METHYL PREDNISOLONE T ablet/ capsule 16mg 49.25
43 OMEPRAZOLE T ablet/ capsule 20 mg 5.41
44 PANTOPRAZOLE T ablet/ capsule 20 mg 20.42
PANTOPRAZOLE T ablet/ capsule 40 mg 33.63

<!-- page 7 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 20 19'05'15
PART I : SEC. (I) - GAZETTE   EXTRAORDINARY   OF   THE   DEMOCRATIC   SOCIALIST   REPUBLIC   OF   SRI   LANKA - 15.05.2019
7A
45 ESOMEPRAZOLE T ablet/ capsule 20 mg 24.26
ESOMEPRAZOLE T ablet/ capsule 40 mg 46.13
46 DOMPERIDONE Tablet/ capsule 10 mg 6.49
47 RABEPRAZOLE T ablet/ capsule 10 mg 13.58
RABEPRAZOLE T ablet/ capsule 20 mg 25.89
48 ALENDRONIC ACID T ablet/ capsule 70 mg 121.80
49 CEFTAZIDIME Injection 500 mg 549.12
CEFTAZIDIME Injection 1 g 915.20
50 CEFTRIAXONE Injection 250 mg 274.56
CEFTRIAXONE Injection 500 mg 514.80
CEFTRIAXONE Injection 1 g 800.80
51 CEFOTAXIME Injection 500 mg 257.40
CEFOTAXIME Injection 1 g 429.00
52 FLUCONAZOLE T ablet/ capsule 50 mg 28.60
FLUCONAZOLE T ablet/ capsule 150 mg 51.48
53 INSULIN SOLUBLE HUMAN Injection 100 IU/1ml 1,372.80
(10ml vial)
INSULIN SOLUBLE HUMAN Injection 100 IU/1ml 686.40
(3ml cartridge)
INSULIN  ISOPHANE  HUMAN Injection 100 IU/1ml 1,372.80
(10ml vial)
INSULIN  ISOPHANE  HUMAN Injection 100 IU/1ml 686.40
(3ml cartridge)
SCHEDULE (Contd.)
MAXIMUM   RETAIL   PRICES   OF   MEDICINES
Column Column II Column III Column IV Column V
I Generic Name Route of S trength Ceiling
Administration/ Maximum
Dosage forms Retail Price
(SLR)

<!-- page 8 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 20 19'05'15
PART I : SEC. (I) - GAZETTE   EXTRAORDINARY   OF   THE   DEMOCRATIC   SOCIALIST   REPUBLIC   OF   SRI   LANKA - 15.05.2019
8A
SCHEDULE (Contd.)
MAXIMUM   RETAIL   PRICES   OF   MEDICINES
Column Column II Column III Column IV Column V
I Generic Name Route of S trength Ceiling
Administration/ Maximum
Dosage forms Retail Price
(SLR)
BIPHASIC   ISOPHANE  INSULIN Injection 100 IU/1ml
(AS INSULIN  SOLUBLE  HUMAN (10 ml vial) 1,372.80
30IU/1ml, INSULIN ISOPHANE
HUMAN 70IU /1ml)
BIPHASIC  ISOPHANE  INSULIN Injection 100 IU/1ml 686.40
(AS INSULIN  SOLUBLE  HUMAN (3 ml cartridge)
30IU/1ml,  INSULIN ISOPHANE
HUMAN 70IU /1ml)
54 GLIMEPIRIDE Tablet 1 mg 8.18
GLIMEPIRIDE Tablet 2 mg 1 1.61
GLIMEPIRIDE Tablet 3 mg 19.45
GLIMEPIRIDE Tablet 4 mg 21.16
55 SITAGLIPTIN T ablet 25 mg 17.16
SITAGLIPTIN T ablet 50 mg 32.60
SITAGLIPTIN TT ablet 100 mg 55.48
56 TAMSULOSIN T ablet/ capsule 0.40 mg 24.02
57 MONTELUKAST T ablet 4 mg 13.73
MONTELUKAST T ablet 5 mg 17.16
MONTELUKAST T ablet 10 mg 24.02
58 PREGABALIN T ablet/ capsule 50 mg 14.01
PREGABALIN T ablet/ capsule 75 mg 17.73
PREGABALIN T ablet/ capsule 100 mg 22.02
PREGABALIN T ablet/ capsule 150 mg 27.46
PREGABALIN T ablet/ capsule 300 mg 45.19

<!-- page 9 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 20 19'05'15
PART I : SEC. (I) - GAZETTE   EXTRAORDINARY   OF   THE   DEMOCRATIC   SOCIALIST   REPUBLIC   OF   SRI   LANKA - 15.05.2019
9A
SCHEDULE (Contd.)
MAXIMUM   RETAIL   PRICES   OF   MEDICINES
Column Column II Column III Column IV Column V
I Generic Name Route of S trength Ceiling
Administration/ Maximum
Dosage forms Retail Price
(SLR)
05 - 755
PRINTED AT THE DEPARTMENT OF GOVERNMENT PRINTING ,  SRI LANKA.
59 TOPIRAMATE T ablet/ capsule 25 mg 22.88
TOPIRAMATE T ablet/ capsule 50 mg 36.61
TOPIRAMATE T ablet/ capsule 100 mg 59.49
60 LAMOTRIGINE T ablet 25 mg 13.73
LAMOTRIGINE T ablet 50 mg 24.02
LAMOTRIGINE T ablet 100 mg 40.04